Group 1 - The core viewpoint of the article is that Meirui New Materials (300848) has responded to investor inquiries regarding the market situation of its products, indicating that detailed information will be available in the company's regular reports [1]

Core Viewpoint - The company, Meirui New Materials, has established itself as a leading supplier in the domestic market with its PPDI facility, which is the largest industrial-scale facility globally [2] Group 1: Company Positioning - The PPDI facility located in Henan is currently the largest of its kind in the world [2] - The company is actively collaborating with international industry benchmark enterprises to expand its overseas market presence [2] Group 2: Product Performance - The company's PPDI products demonstrate superior performance in key indicators compared to similar competitors, showcasing higher stability and greater added value [2] - The company holds independent intellectual property rights for this product, although specific technical parameters and quantitative comparisons cannot be disclosed due to commercial confidentiality [2]

Core Viewpoint - The company is steadily and orderly releasing production capacity for its products in response to market demand and customer development progress, which is expected to enhance its competitive edge in the specialty isocyanates and amines market [1] Group 1: Company Developments - The company's subsidiary in Henan is ramping up production capacity in line with market orders and customer development [1] - The specialty isocyanates and amines produced by the company utilize advanced international processes, resulting in high technical added value and superior performance [1] - The new production capacity is anticipated to stabilize the supply of specialty monomer materials, contributing to significant economies of scale and reinforcing cost advantages [1] Group 2: Industry Impact - Large-scale industrial production is expected to provide better quality and more economical raw material solutions for downstream applications [1] - The company's efforts aim to enable more customers to access high-performance specialty monomer materials, thereby promoting industry development [1]

Core Viewpoint - Meirui New Materials (300848) has established a competitive advantage in the TPU sector through differentiated products and efficient, low-cost supply capabilities [1] Group 1 - The company has developed a certain competitive edge in the TPU field after years of development [1] - The company is expanding its upstream supply chain through a project in Henan, focusing on the development of specialty isocyanate products [1] - This initiative aims to ensure stable supply and low-cost production of specialty raw materials for polyurethane new materials, enhancing the company's risk resistance and core competitiveness [1]

证券日报网讯1月8日，美瑞新材（300848）在互动平台回答投资者提问时表示，公司始终高度重视河南 项目的建设与运营，项目的投产达效本身是一个逐步推进的过程，涉及复杂的工艺调试与客户认证环 节。目前，公司正积极协调资源，全力推进河南的客户验证工作与生产计划协调，力争早日实现项目达 产达效。 ...

Core Viewpoint - Meirui New Materials (300848) is accelerating the construction of its 10,000-ton expandable thermoplastic polyurethane elastomer project, with progress aligning with expectations [1] Group 1: Project Development - The company is advancing its project for producing 10,000 tons of expandable thermoplastic polyurethane elastomers as planned [1] - The construction progress is in line with the company's expectations [1] Group 2: Product Characteristics and Market Potential - The self-developed foamed TPU represents a new application of TPU in the footwear sector, characterized by lightweight and high rebound properties [1] - Foamed TPU is easy to process and is typically used in the midsoles of sports shoes, indicating a favorable market development outlook [1] Group 3: Competitive Advantage - The core raw material for foamed TPU is HDI, which has synergistic advantages with the company's Henan project [1] - With the production launch of HDI in Henan, the competitive advantage of the company's foamed TPU is expected to strengthen, facilitating market sales and expansion [1]

美瑞新材（300848.SZ）1月8日在投资者互动平台表示，我司没有与杭高院合作芳香胺等工艺的相关项 目。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：董秘你好，公司与杭高院合作的芳香胺新工艺降本 40%，年节约成本超3亿元，2026年Q2将规模化投产，请问目前中试进展是否超预期？ ...

格隆汇1月8日丨美瑞新材(300848.SZ)在投资者互动平台表示，我司没有与杭高院合作芳香胺等工艺的 相关项目。 ...

证券代码：300848 证券简称：美瑞新材 公告编号：2025-081 美瑞新材料股份有限公司 关于使用部分闲置募集资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 美瑞新材料股份有限公司（以下简称"公司"）于2025年3月15日召开第四届董事会第四 次会议、第四届监事会第四次会议，审议通过了《关于使用部分闲置募集资金进行现金管理 的议案》，同意公司在确保不影响募集资金投资项目建设和募集资金安全的情况下，使用合 计不超过1.95亿元（含本数）的闲置募集资金进行现金管理，上述额度有效期自董事会审议 通过之日起一年内有效，在前述额度和期限范围内可循环滚动使用。闲置募集资金现金管理 到期后将及时归还至募集资金专户。并授权董事长或董事长授权的其他人士行使该项投资决 策权及签署相关合同文件，并由财务部负责具体的购买事宜。具体内容详见公司披露于巨潮 资讯网（www.cninfo.com.cn）的《关于使用部分闲置募集资金进行现金管理的公告》（公告 编号：2025-012）。 近日，公司使用部分闲置募集资金购买了现金管理产品，现将相关事宜公告如下： ...

证券代码：300848 证券简称：美瑞新材 公告编号：2025-082 美瑞新材料股份有限公司 关于使用部分闲置自有资金购买理财产品的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 美瑞新材料股份有限公司（以下简称"公司"）于 2025 年 4 月 19 日召开第四届董事 会第五次会议、第四届监事会第五次会议，审议通过了《关于使用部分闲置自有资金购买 理财产品的议案》，同意公司及子公司在确保不影响公司正常生产经营的资金需求和资金 安全的情况下，使用合计不超过 5 亿元（含本数）的闲置自有资金购买理财产品，上述额 度有效期自本次董事会审议通过之日起一年内有效，在前述额度和期限范围内可循环滚动 使用，并授权公司管理层及子公司在上述额度内签署相关合同文件，具体事项由财务部负 责组织实施。具体内容详见公司于2025年4月22日披露于巨潮资讯网（www.cninfo.com.cn） 的《关于使用部分闲置自有资金购买理财产品的公告》（公告编号：2025-033）。 近日，公司及子公司使用部分闲置自有资金购买了理财产品，现将相关事宜公告如下： 一、本次购买理财产品 ...